Ttbio Corp. (TPEX:6493)
Taiwan · Delayed Price · Currency is TWD 53.40
-0.40 (-0.74%)
Sep 9, 2025, 1:53 PM CST
Ttbio Market Cap
Ttbio has a market cap or net worth of 1.78 billion as of September 9, 2025. Its market cap has increased by 264.38% in one year.
Market Cap
1.78B
Enterprise Value
1.93B
Revenue
392.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.40
Market Cap Chart
Since January 8, 2015, Ttbio's market cap has increased from 1.19B to 1.78B, an increase of 49.43%. That is a compound annual growth rate of 3.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 1.62B | 237.80% |
| Dec 30, 2024 | 478.60M | -8.92% |
| Dec 26, 2023 | 525.49M | -19.22% |
| Dec 28, 2022 | 650.55M | 21.30% |
| Dec 30, 2021 | 536.32M | 2.53% |
| Dec 31, 2020 | 523.09M | -27.01% |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 395.51B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 90.84B |
| Lotus Pharmaceutical | 50.62B |
| Lumosa Therapeutics | 40.77B |
| Oneness Biotech | 36.44B |
| Polaris Group | 29.47B |
| Center Laboratories | 28.63B |